Cargando…

Clinical value of detecting autoantibodies against β(1)-, β(2),- and α(1)-adrenergic receptors in carvedilol treatment of patients with heart failure

OBJECTIVE: To determine the possible association of anti-β(1)-adrenergic receptors (anti-β(1)-AR), anti-β(2)-AR and anti-α(1)-AR with carvedilol treatment in patients with heart failure (HF). METHODS: A total of 267 HF patients were prospectively enrolled. Blood samples were measured by an enzyme-li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Dong-Yan, Xu, Lin, Zhang, Zhi-Yong, Xu, Xiao-Rong, Wang, Xin, Zhang, Juan, Liu, Jia-Mei, Wang, Hua, Chen, Jin, Zhang, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338933/ https://www.ncbi.nlm.nih.gov/pubmed/32670360 http://dx.doi.org/10.11909/j.issn.1671-5411.2020.06.002

Ejemplares similares

Gα(i) is required for carvedilol-induced β(1) adrenergic receptor β-arrestin biased signaling
por: Wang, Jialu, et al.
Publicado: (2017)

Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β(1)-Adrenergic Receptors
por: Park, Misun, et al.
Publicado: (2018)

Prognostic Value of β1 Adrenergic Receptor Autoantibody and Soluble Suppression of Tumorigenicity-2 in Patients With Acutely Decompensated Heart Failure
por: Sun, Yanxiang, et al.
Publicado: (2022)

Diagnostic and prognostic value of autoantibodies against β(1)-adrenoreceptors in patients with heart failure following acute myocardial infarction: A 5-year prospective study
por: Wang, Xin, et al.
Publicado: (2020)

MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors
por: Han, Sang-oh, et al.
Publicado: (2012)

Gi-protein-coupled β (1)-adrenergic receptor: re-understanding the selectivity of β (1)-adrenergic receptor to G protein : Gi-protein-coupled β (1)-adrenergic receptor
por: Chen, Hao, et al.
Publicado: (2022)

Impact of human autoantibodies on β(1)-adrenergic receptor conformation, activity, and internalization
por: Bornholz, Beatrice, et al.
Publicado: (2013)

Increased circulating β(2)-adrenergic receptor autoantibodies are associated with smoking-related emphysema
por: Hu, Jia-yi, et al.
Publicado: (2017)

β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and Prognosis
por: Liu, Wen-Nan, et al.
Publicado: (2012)

Decreased Autophagy in Rat Heart Induced by Anti-β1-Adrenergic Receptor Autoantibodies Contributes to the Decline in Mitochondrial Membrane Potential
por: Wang, Li, et al.
Publicado: (2013)

Biased activation of β(2)-AR/Gi/GRK2 signal pathway attenuated β(1)-AR sustained activation induced by β(1)-adrenergic receptor autoantibody
por: Chen, Hao, et al.
Publicado: (2021)

The IgG3 subclass of β1-adrenergic receptor autoantibodies is an endogenous biaser of β1AR signaling
por: Mohan, Maradumane L., et al.
Publicado: (2021)

Effect of prazosin on diabetic nephropathy patients with positive α1-adrenergic receptor autoantibodies and refractory hypertension
por: ZHAO, LIN-SHUANG, et al.
Publicado: (2015)

Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes
por: Casabella-Ramón, Sergi, et al.
Publicado: (2022)

Carvedilol ameliorates dexamethasone-induced myocardial injury in rats independent of its action on the α1-adrenergic receptor
por: Mohamed, Rasha M. S. M., et al.
Publicado: (2022)

Author Correction: Increased circulating β2-adrenergic receptor autoantibodies are associated with smoking-related emphysema
por: Hu, Jia-yi, et al.
Publicado: (2020)

Unique Positive Cooperativity Between the β-Arrestin–Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor
por: Pani, Biswaranjan, et al.
Publicado: (2021)

Circulating β(1) Adrenergic Autoantibodies from Patients with Chronic Periodontitis Interact with Gingival Fibroblasts
por: Sterin-Borda, Leonor, et al.
Publicado: (2009)

β(1) Adrenergic Receptor Autoantibodies and IgG Subclasses: Current Status and Unsolved Issues
por: Kawai, Akane, et al.
Publicado: (2023)

Potential Relevance of α(1)-Adrenergic Receptor Autoantibodies in Refractory Hypertension
por: Wenzel, Katrin, et al.
Publicado: (2008)

Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial
por: Clark, Andrew L., et al.
Publicado: (2017)

Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis
por: Shang, Luxiang, et al.
Publicado: (2020)

Honokiol Protects against Anti-β1-Adrenergic Receptor Autoantibody-Induced Myocardial Dysfunction via Activation of Autophagy
por: Wei, Xi-qing, et al.
Publicado: (2018)

β-Adrenergic receptor signaling in cardiac function and heart failure
por: Madamanchi, Aasakiran
Publicado: (2007)

Effect of hydroxylpropyl-β-cyclodextrin on Solubility of Carvedilol
por: Shewale, B. D., et al.
Publicado: (2008)

How Carvedilol activates β(2)-adrenoceptors
por: Benkel, Tobias, et al.
Publicado: (2022)

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure
por: Zhang, Xiaojian, et al.
Publicado: (2016)

β-Adrenergic Receptor Desensitization/Down-Regulation in Heart Failure: A Friend or Foe?
por: Mahmood, Abrahim, et al.
Publicado: (2022)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma
por: Jünemann, Anselm, et al.
Publicado: (2018)

Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2019)

β2 adrenergic receptor activation governs cardiac repolarization and arrhythmogenesis in a guinea pig model of heart failure
por: Wang, Yao, et al.
Publicado: (2015)

Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study
por: Lee, Hae-Young, et al.
Publicado: (2016)

Adiponectin up‐regulates the decrease of myocardial autophagic flux induced by β(1)‐adrenergic receptor autoantibody partly dependent on AMPK
por: Sun, Cong, et al.
Publicado: (2021)

How carvedilol does not activate β(2)-adrenoceptors
por: Lefkowitz, Robert J., et al.
Publicado: (2023)

Investigating Carvedilol’s Repurposing for the Treatment of Non-Small Cell Lung Cancer via Aldehyde Dehydrogenase Activity Modulation in the Presence of β-Adrenergic Agonists
por: Ikhmais, Balqis A., et al.
Publicado: (2023)

Serum Positive for the Autoantibody against the β (1)-Adrenoceptor from Chinese Patients with Congestive Heart Failure Decreases I (ss) in Mouse Cardiac Myocytes
por: Wang, Yuan-yuan, et al.
Publicado: (2011)

Inhibitory and Agonistic Autoantibodies Directed Against the β(2)-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2021)

Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure
por: Markousis-Mavrogenis, George, et al.
Publicado: (2023)

T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure
por: Crocini, Claudia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_99kp72ab64harnsqddfnmrd5kt